Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Chemotherapy for colorectal cancer.

Meyers BM, Dhesy B, Zbuk K.

Lancet Oncol. 2012 Jan;13(1):e3-4; author reply e4. doi: 10.1016/S1470-2045(11)70421-1. No abstract available.

PMID:
22225722
2.

Palliative chemotherapy in elderly patients with metastatic colorectal cancer: do we know how it should be used?

Sorbye H.

Acta Oncol. 2012 Sep;51(7):819-21. doi: 10.3109/0284186X.2012.708106. Epub 2012 Aug 29. No abstract available.

PMID:
22928691
3.

Sequential chemotherapy for colorectal cancer.

Seymour M.

Lancet Oncol. 2011 Oct;12(11):987-8. doi: 10.1016/S1470-2045(11)70233-9. Epub 2011 Sep 6. No abstract available.

PMID:
21903471
4.

Chemotherapy-free intervals for patients with metastatic colorectal cancer remain an option.

Maughan T, Adams R, Wilson R, Seymour M, Meade A, Kaplan R.

J Clin Oncol. 2010 Jun 10;28(17):e275-6; author reply e277-8. doi: 10.1200/JCO.2009.27.8218. Epub 2010 May 3. No abstract available.

5.

Costs of chemotherapy in the treatment of colorectal cancer.

Jansman FG, Postma MJ.

Eur J Health Econ. 2006 Jun;7(2):145-6. No abstract available.

PMID:
16699776
6.

[Progress of chemotherapy in colorectal cancer].

Komatsu Y.

Gan To Kagaku Ryoho. 2007 Nov;34(11):1771-6. Review. Japanese. No abstract available.

PMID:
18064761
7.

Exploring better strategies for EGFR antibodies in colon cancer.

Cervantes A.

Lancet Oncol. 2014 May;15(6):549-50. doi: 10.1016/S1470-2045(14)70137-8. Epub 2014 Apr 3. No abstract available.

8.

The role of regorafenib in metastatic colorectal cancer.

Riechelmann R, Grothey A.

Lancet Oncol. 2015 Jun;16(6):596-7. doi: 10.1016/S1470-2045(15)70191-9. Epub 2015 May 13. No abstract available.

PMID:
25981811
9.

Comment on 'Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab'.

Bibeau F, Gil H, Castan F, Boissière-Michot F.

Br J Cancer. 2013 Dec 10;109(12):3127-9. doi: 10.1038/bjc.2013.651. Epub 2013 Oct 24. No abstract available.

10.

Reply: Comment on 'Histopathologic evaluation of liver metastases from colorectal cancer patients treated with FOLFOXIRI plus bevacizumab'.

Schirripa M, Loupakis F, Pollina L, Cremolini C, Pasquini G, Falcone A.

Br J Cancer. 2013 Dec 10;109(12):3129-30. doi: 10.1038/bjc.2013.652. Epub 2013 Oct 24. No abstract available.

11.

Capecitabine plus oxaliplatin in metastatic colorectal cancer.

Cassidy J.

J Clin Oncol. 2007 Nov 1;25(31):5043-5; author reply 5045-6. No abstract available.

12.
13.

Response to "Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting".

Moore M, Kosmider S, Field K, Desai J, Lim L, Barnett F, Gibbs P.

Oncologist. 2009 Jan;14(1):104-5; author reply 106-7. No abstract available.

14.

Chemotherapy-free intervals in patients with metastatic colorectal cancer: a tale of two cities?

Beretta GD, Scartozzi M, Tondulli L, Cascinu S.

J Clin Oncol. 2010 Jun 1;28(16):e268-9; author reply e270. doi: 10.1200/JCO.2009.27.4720. Epub 2010 Apr 12. No abstract available.

15.

Can mitomycin C represent a valid partner for 5-fluorouracil in second-line chemotherapy of colorectal cancer?

Tassinari D, Arcangeli V, Panzini I, Sartori S, Gianni L, Ravaioli A.

Ann Oncol. 2000 Aug;11(8):1071. No abstract available.

16.

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.

Pignon JP, Ducreux M.

N Engl J Med. 2001 Jan 25;344(4):306; author reply 306-7. No abstract available.

PMID:
11191663
17.

Bevacizumab plus oxaliplatin-based regimens for the treatment of colorectal cancer.

Scheithauer W, Schmiegel W.

Onkologie. 2009 Jul;32(7):431-9. doi: 10.1159/000218354. Epub 2009 Jun 10. Review.

PMID:
19556824
18.

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.

Erlichman C, Goldberg RM, O'Connell MJ.

N Engl J Med. 2001 Jan 25;344(4):305; author reply 306-7. No abstract available.

PMID:
11191661
19.

Bevacizumab in combination with 5-fluorouracil-based chemotherapy in the second-line treatment of metastatic colorectal cancer.

Benson AB 3rd.

Clin Adv Hematol Oncol. 2006 Oct;4(10):747. Review. No abstract available.

PMID:
17111559
20.

[Questionnaire survey of systemic chemotherapy in colorectal cancer].

Katoh K, Morita T, Kameyama M, Watanabe M, Yoshioka K, Hirai T, Takao Y, Sunouchi K, Ogata Y, Tomita N, Siroto H, Akasu T, Ikeuchi K, Takahashi K, Kubo R.

Gan To Kagaku Ryoho. 2002 Jun;29(6):895-903. Japanese.

PMID:
12090041
Items per page

Supplemental Content

Write to the Help Desk